Inhibin A and B, Tumor Marker
Proteins called inhibins are secreted by cells in the ovary (granulose cells) and testis (Sertoli cells). The inhibins have two subunits: Alpha (A) and Beta (B). In women, the levels of these two hormones fluctuate with the menstrual cycle. Inhibin A is the predominant of the two inhibins. However, B plays a role as a follicle matures, and the levels peak two days after the peak of LH (luteinizing hormone). The LH peak usually occurs mid cycle. Moving through the menstrual cycle, the levels of both inhibin A and B decline with the depletion of the ovarian follicles.
Ovarian cancer is divided into three types: epithelial, germ cell, and sex cord-stromal tumors. The majority of the sex cord-stromal tumors are further categorized as granulose cell tumors. Due to the fluctuations of the levels of inhibin A and B, it is difficult to use as a tumor marker in pre-menopausal women. As a fertility marker, the inhibins are useful for determining ovarian reserve. The amount of follicles declines with age. The number of follicles contained within the ovary at any given time is called the ovarian reserve. Additional tests, including inhibin B measured at specific timelines during the menstrual cycle, can allow the estimation of ovarian reserve. This can help in evaluating success during fertility treatment. In men, with information from FSH measurements, inhibin will be decreased in men with infertility.
In addition to their utility for prenatal screening for Down Syndrome and other prenatal trisomy, inhibins can be used as a marker for diagnosis of granulosa cell tumors, mucinous epithelial ovarian tumors and other ovarian related tumors and cancers.
- Diagnose and monitor Granulosa Cell-Tumor
- Diagnose and monitor Mucinous Epithelial Ovarian Tumor
- Follow-up to infertility evaluation
Increased in:
- Granulosa Cell Tumors
- Mucinous Epithelial Ovarian Tumors
- Residual or progressive disease for patients after surgery for ovarian cancer
Decreased in:
- Infertility
| Inhibin A – Normal Cycling Females | Reference Range |
| Early Follicular Phase (-14 to -10) | 5.5-28.2 pg/mL |
| Mid Follicular Phase (-9 to -4) | 7.9-34.5 pg/mL |
| Late Follicular Phase (-3 to -1) | 19.5-102.3 pg/mL |
| Mid Cycle (Day 0) | 49.9-155.5 pg/mL |
| Early Luteal (1 to 3) | 35.9 - 132.7 pg/mL |
| Mid Luteal (4 to 11) | 13.2 - 159.6 pg/mL |
| Late Luteal (12 to 14) | 7.3 - 89.9 pg/mL |
| Inhibin A – Other Populations | Reference Range |
| IVF-Peak Levels | 354.2 - 1690.0 pg/mL |
| PCOS-Ovulatory | 5.7 - 16.0 pg/mL |
| Postmenopausal | 1.0 - 3.9 pg/mL |
| Normal males | 1.0 - 3.6 pg/mL |
| Inhibin B – Males | Reference Range |
| 0-23 months | <430 pg/mL |
| 2-4 years | <269 pg/mL |
| 5-7 years | <184 pg/mL |
| 8-10 years | <214 pg/mL |
| 11-13 years | <276 pg/mL |
| 14-17 years | <273 pg/mL |
| Adults | <399 pg/mL |
| Inhibin B – Females | Reference Range |
| 0-23 months | <111 pg/mL |
| 2-4 years | <44 pg/mL |
| 5-7 years | <27 pg/mL |
| 8-10 years | <67 pg/mL |
| 11-13 years | <120 pg/mL |
| 14-17 years | <136 pg/mL |
| Inhibin B – Premenopausal Status | Reference Range |
| Follicular | <139 pg/mL |
| Luteal | <92 pg/mL |
| Postmenopausal | <10 pg/mL |
Serum (SST).
Stability
- Ambient: 12 hours
- Refrigerated: 7 days
- Frozen: 1 month
- Gynecol Obstet Fertil. 2004 Sep;32(9):767-70. [PMID: 15380760]
- Hum Reprod Update. 2010 Jan-Feb;16(1):39-50. [PMID: 19752047]
- Semin Reprod Med. 2004 Aug;22(3):187-93. [PMID: 15319821]
- Eur J Endocrinol. 2001 Nov;145(5):561-71. [PMID: 11720872]
- Adv Clin Chem. 2008;45:1-29. [PMID: 18429491]
- Semin Reprod Med. 2004 Aug;22(3):195-208. [PMID: 15319822]
- J Clin Endocrinol Metab. 2007 Jul;92(7):2526-31. [PMID: 17473066]
- J Med Screen. 1998;5(3):115-9. [PMID: 9795869]
- Obstet Gynecol Clin North Am. 1997 Mar;24(1):33-47. [PMID: 9086517]